Medical News

RSS

New, HIV-like retroviruses linked to CFS, prostate cancer detected in healthy blood donors

In an unprecedented move, chronic fatigue syndrome patients published a half-page ad in The Washington Post today. The ad brings attention to new, HIV-like retroviruses, including XMRV, which have been linked to CFS and aggressive prostate cancer, and have been detected in healthy blood donors.

6 Dec 2010

Nation's top insurance lawyer suggests people to take steps before changing health insurance policy

By now, Americans everywhere are receiving premium increases and new policy choices when it comes to healthcare. Subscribers' rates are increasing and companies are making decisions about what they plan to do with the rising costs heading their way, says Frank N. Darras, the nation's top insurance lawyer.

6 Dec 2010

Alexithymia associated with insecure attachment styles, emotional trauma: Research

Alexithymia is inversely related to mentalization and is associated with insecure attachment styles and emotional trauma, which influence the capacity to regulate affects induced by stressful events. Alexithymia and intrapsychic conflicts may both contribute to the pathogenesis of panic attacks.

6 Dec 2010

Performance of Myconostica's MycAssay Aspergillus in CF reported at British Thoracic Society meeting

At the prestigious annual British Thoracic Society meeting in London on December 1st, Dr Caroline Baxter reported the highly sensitive performance of Myconostica's real-time PCR assay MycAssayTM Aspergillus in cystic fibrosis sputum which is 260% more sensitive than the currently used culture.

6 Dec 2010

HHS, U.S. Treasury Department recognize Integrated Medical Systems' technolgy

The medical technology developed by Integrated Medical Systems, Inc., has been recognized by the U.S. Department of Health and Human Services and the U.S. Treasury Department as a "qualified therapeutic discovery." The designation earns the company a grant to off-set its development efforts. The Qualifying Therapeutic Discovery Project designation and grant is provided for under the Patient Protection and Affordable Care Act of 2010.

6 Dec 2010

$Allos Therapeutics reports new analysis of PROPEL trial data of FOLOTYN in patients with refractory PTCL$

Allos Therapeutics reports new analysis of PROPEL trial data of FOLOTYN in patients with refractory PTCL

Allos Therapeutics, Inc. today reported new analysis of data from the Company's pivotal PROPEL trial of FOLOTYN (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma at the 52nd American Society of Hematology Annual Meeting in Orlando, Florida.

6 Dec 2010

NovaBay Pharmaceuticals, Galderma expand their multi-year collaboration agreement

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, and Galderma, a global leading pharmaceutical company dedicated exclusively to the field of dermatology, announce the expansion of their multi-year collaboration agreement. Based on positive data assessing the activity of NovaBay's Aganocide compounds against impetigo, Galderma has agreed to exercise its option for this indication.

6 Dec 2010

MenAfriVac to help health workers eliminate meningococcal A epidemics

The West African nation of Burkina Faso today became the first country to begin a nationwide campaign to introduce a new meningitis vaccine that promises to rid the entire region of the primary cause of epidemic meningitis. The first vaccine designed specifically for Africa, MenAfriVac is expected to help health workers eliminate meningococcal A epidemics in the 25 countries of the meningitis belt, stretching from Senegal in the west to Ethiopia in the east.

6 Dec 2010

GP Medical, Beijing Yuande named in Deloitte Technology Fast 500 Asia Pacific 2010 program

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced that its wholly-owned subsidiaries, Beijing GP Medical Technologies Co., Ltd. and Beijing Yuande Bio-Medical Engineering Co., Ltd., have been ranked 12th and 415th, respectively, in the Deloitte Technology Fast 500 Asia Pacific 2010 program.

6 Dec 2010

Annual BioPartnering China conference launched at Renaissance Shanghai Pudong Hotel

The 3rd Annual BioPartnering China conference, co-produced by TVG and the Zhangjiang Biotech Pharmaceutical Base, launched today at the Renaissance Shanghai Pudong Hotel. The conference attracts a global representation of industry leaders from China, Europe and the USA.

6 Dec 2010

ConvaTec Healthcare offers $1,870,000,000 in Senior Secured Notes, Senior Notes

ConvaTec Healthcare, a world-leading developer, manufacturer and marketer of innovative medical technologies for community and hospital care, today announced that in connection with a refinancing of its debt under its existing senior secured and mezzanine facilities and in combination with new senior secured credit facilities, it is offering $1,870,000,000 (equivalent) in Senior Secured Notes and Senior Notes.

6 Dec 2010

Elsevier announces title change for Cancer Genetics and Cytogenetics journal

Elsevier, the world's leading publisher of scientific, technical and medical information, announced today that its highly respected Cancer Genetics and Cytogenetics journal is changing its title to Cancer Genetics and has named Dr. Jaclyn A. Biegel as editor-in-chief.

6 Dec 2010

Risk of heart attack increases soon after RA diagnosis: Research

The risk of having a heart attack is 60 per cent higher just a year after a patient has been diagnosed with rheumatoid arthritis, according to research published in the December issue of the Journal of Internal Medicine.

6 Dec 2010

O2h signs agreement to provide chemistry, ADME services to Phytopharm

Executives from Phytopharm Plc (Huntingdon,UK) signed an agreement with O2h (Cambridge, UK, Ahmedabad, India) under which O2h will provide chemistry and ADME services to support drug discovery initiatives at Phytopharm.

6 Dec 2010

Researchers show link between accepting family attitudes, behaviors towards LGBT children

For the first time, researchers have established a clear link between accepting family attitudes and behaviors towards their lesbian, gay, bisexual and transgender children and significantly decreased risk and better overall health in adulthood.

6 Dec 2010

Telik announces positive results from Phase 2 trial of ezatiostat in patients with MDS

Telik, Inc. today announced positive results from a Phase 2 multicenter trial of oral ezatiostat hydrochloride (TELINTRA, TLK199) in patients with an International Prognostic System Score of low to intermediate-1 risk myelodysplastic syndrome.

6 Dec 2010

MBH receives prestigious 2010 Healthcare IT Summit Innovation Award

Autonomy Corporation plc, a global leader in infrastructure software for the enterprise, today announced that Autonomy Meaning Based Healthcare received the prestigious 2010 Healthcare IT Summit Innovation Award for "Solution With Greatest Market Potential." Autonomy was selected for this award by attendees at the 2010 Healthcare IT Summit, including leading healthcare delivery organizations and insurance providers such as Massachusetts General Hospital, University of Pennsylvania Health System, Johns Hopkins Healthcare, UnitedHealth Group, and CIGNA.

6 Dec 2010

$Updated Phase 1 study data of ponatinib in patients with refractory CML, Ph+ ALL presented at ASH$

Updated Phase 1 study data of ponatinib in patients with refractory CML, Ph+ ALL presented at ASH

ARIAD Pharmaceuticals, Inc. today announced updated clinical data from a fully enrolled and ongoing Phase 1 study of its investigational pan-BCR-ABL inhibitor, ponatinib, in patients with resistant and refractory chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia.

6 Dec 2010

Study confirms importance of EEG as diagnostic tool in ICU

Bleeding in and around the brain (cerebral hemorrhage, including intra-cerebral hemorrhage, subdural hematoma, subarachnoid hemorrhage among other forms), from whatever cause (stroke, ruptured aneurysm, stroke, tumor, trauma, etc) can be very irritating to the electrical cells of the brain and affect how these cells transmit signals. If cells become very irritated and/or hyperactive, seizures can occur.

6 Dec 2010

Genentech announces Phase II study results of RG1678 for treatment of schizophrenia

Genentech, Inc., a member of the Roche Group, today announced eight-week results from a Phase II study of RG1678, its investigational first-in-class glycine reuptake inhibitor for the treatment of schizophrenia.

6 Dec 2010

Medical News

New, HIV-like retroviruses linked to CFS, prostate cancer detected in healthy blood donors

Nation's top insurance lawyer suggests people to take steps before changing health insurance policy

Alexithymia associated with insecure attachment styles, emotional trauma: Research

Performance of Myconostica's MycAssay Aspergillus in CF reported at British Thoracic Society meeting

HHS, U.S. Treasury Department recognize Integrated Medical Systems' technolgy

Allos Therapeutics reports new analysis of PROPEL trial data of FOLOTYN in patients with refractory PTCL

NovaBay Pharmaceuticals, Galderma expand their multi-year collaboration agreement

MenAfriVac to help health workers eliminate meningococcal A epidemics

GP Medical, Beijing Yuande named in Deloitte Technology Fast 500 Asia Pacific 2010 program

Annual BioPartnering China conference launched at Renaissance Shanghai Pudong Hotel

ConvaTec Healthcare offers $1,870,000,000 in Senior Secured Notes, Senior Notes

Elsevier announces title change for Cancer Genetics and Cytogenetics journal

Risk of heart attack increases soon after RA diagnosis: Research

O2h signs agreement to provide chemistry, ADME services to Phytopharm

Researchers show link between accepting family attitudes, behaviors towards LGBT children

Telik announces positive results from Phase 2 trial of ezatiostat in patients with MDS

MBH receives prestigious 2010 Healthcare IT Summit Innovation Award

Updated Phase 1 study data of ponatinib in patients with refractory CML, Ph+ ALL presented at ASH

Study confirms importance of EEG as diagnostic tool in ICU

Genentech announces Phase II study results of RG1678 for treatment of schizophrenia

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News